DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Hirschfield GM, Chazouillères O, Drenth JP. et al.
Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: a multicenter, randomized, double-blind, placebo-controlled phase II trial.
J Hepatol 2019;
70 (03) 483-493
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.